Document Type
Article
Publication Date
February 2024
Patent Number
11911481
Abstract
This invention provides for a RSV-targeted nanoparticle PMN (RTPMN), combining HR2D anti-fusion peptide, and plasmid encoded siRNA against RSV-NS1 and/or RSV-P gene as a safe, effective and inexpensive anti-RSV prophylaxis and/or therapy.
Application Number
17/057153
Recommended Citation
Markoutsa, Eleni; Mohapatra, Subhra; and Mohapatra, Shyam, "Compositions and methods for treating RSV-infections" (2024). USF Patents. 1408.
https://digitalcommons.usf.edu/usf_patents/1408
Assignees
UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Filing Date
05/21/2019
COinS
